Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (4): 755-757. doi: 10.19723/j.issn.1671-167X.2023.04.030
Previous Articles Next Articles
Yuan-yuan XU1,Zhi-lin SUN1,Xiu-lian ZHANG1,Zi-lian LIU1,Wei LIU2,Xin GUAN1,*()
CLC Number:
1 | 赵辨. 中国临床皮肤病学[M]. 南京: 江苏凤凰科学技术出版社, 2017: 799- 800. |
2 |
Choo SY . The HLA system: Genetics, immunology, clinical testing, and clinical implications[J]. Yonsei Med J, 2007, 48 (1): 11- 23.
doi: 10.3349/ymj.2007.48.1.11 |
3 | 程晓东, 张莹, 胡玉皎, 等. 临床患者检测卡马西平药物基因位点在预防Steven-Johnson综合征和中毒性表皮坏死松解症中的应用[J]. 现代检验医学杂志, 2019, 34 (4): 15- 17. |
4 |
Hsiao YH , Hui RC , Wu T , et al. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations[J]. J Dermatol Sci, 2014, 73 (2): 101- 109.
doi: 10.1016/j.jdermsci.2013.10.003 |
5 |
McCormack M , Alfirevic A , Bourgeois S , et al. HLA-A * 3101 and carbamazepine-induced hypersensitivity reactions in Europeans[J]. N Engl J Med, 2011, 364 (12): 1134- 1143.
doi: 10.1056/NEJMoa1013297 |
6 |
Ozeki T , Mushiroda T , Yowang A , et al. Genome-wide association study identifies HLA-A3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population[J]. Hum Mol Genet, 2011, 20 (5): 1034- 1041.
doi: 10.1093/hmg/ddq537 |
7 |
Chung WH , Hung SI , Hong HS , et al. Medical genetics: A marker for Stevens-Johnson syndrome[J]. Nature, 2004, 428 (6982): 486.
doi: 10.1038/428486a |
8 |
刘琛. 卡马西平致严重皮肤反应与HLA-A * 3101等位基因有关[J]. 药物不良反应杂志, 2012, 14 (6): 400.
doi: 10.3760/j.issn.1008-5734.2012.06.024 |
9 | 英国药品和健康产品管理局. 警告含HLA-A * 3101等位基因患者服用卡马西平更易发生严重皮肤反应[J]. 中国药物评价, 2013, 30 (1): 12. |
10 |
Amstutz U , Shear NH , Rieder MJ , et al. Recommendations for HLA-B * 1502 and HLA-A * 3101 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions[J]. Epilepsia, 2014, 55 (4): 496- 506.
doi: 10.1111/epi.12564 |
11 |
He XJ , Jian LY , He XL , et al. Association between the HLA-B * 1502 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China[J]. Pharmacol Rep, 2013, 65 (5): 1256- 1262.
doi: 10.1016/S1734-1140(13)71483-X |
12 |
秦兵, 民福利, 石奕武, 等. 中国南方汉族人群中卡马西平导致SJS/TEN与HLA-B基因的相关性[J]. 实用医学杂志, 2012, 28 (13): 2136- 2139.
doi: 10.3969/j.issn.1006-5725.2012.13.013 |
13 |
Nguyen DV , Chu HC , Nguyen DV , et al. HLA-B * 1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese[J]. Asia Pac Allergy, 2015, 5 (2): 68- 77.
doi: 10.5415/apallergy.2015.5.2.68 |
14 |
Khor AH , Lim KS , Tan CT , et al. HLA-A * 3101 and HLA-B * 1502 association with Stevens-Johnson syndrome and toxic epidermal necrolysis to carbamazepine in a multiethnic Malaysian population[J]. Pharmacogenet Genomics, 2017, 27 (7): 275- 278.
doi: 10.1097/FPC.0000000000000287 |
15 | Genin E , Chen DP , Hung SI , et al. HLA-A * 3101 and different types of carbamazepine-induced severe cutaneous adverse reactions: An international study and meta-analysis[J]. Pharma-cogenomics J, 2014, 14 (3): 281- 288. |
[1] | XU Yan, LIU Xian-Zeng, GAO Xu-Guang. Paroxysmal kinesigenic dyskinesia: 2 case reports [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 659-661. |
|